Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment January 10, 2025
Blocking epigenetic “Swiss army knife” may be a new strategy for treating colorectal cancer – Van Andel Institute November 1, 2024
Takeda Receives Approval for FRUZAQLA (fruquintinib) in Japan for the Treatment of Unresectable Advanced or Recurrent Colorectal Cancer September 24, 2024
